Literature DB >> 28275973

Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.

Hallvard Reigstad1, Berit Woldseth2, Johannes Häberle3.   

Abstract

A girl born at term was admitted to the neonatal intensive care unit because of mild respiratory distress after a complicated delivery. She recovered, but was readmitted at 58 h of life with mild respiratory distress and increased muscle tone. Neonatal abstinence syndrome because of maternal use of lithium, clomipramine, and quetiapine during pregnancy was suspected, but at 115 h of life she became unresponsive, and an immediate work-up for coma was initiated. An ammonia of 2,235 μmol/l was found, and treatment with sodium benzoate, sodium phenylacetate, arginine, glucose, and N-carbamylglutamate (NCG, Carbaglu®) was started. This treatment normalized plasma ammonia levels within 16 h.Biochemical results suggested a mitochondrial urea cycle defect, either of N-acetyl glutamate synthase (NAGS) or carbamoyl phosphate synthetase 1. DNA analysis later confirmed a diagnosis of NAGS deficiency. Under long-term treatment with NCG, the patient developed normally at last follow-up at 7 months of age.In conclusion, the standard neonatal situation of a neurologically compromised newborn turned out as a treatable rare inborn error of metabolism. In all neonates with somnolence and coma and hence the suspicion of a bacterial sepsis, plasma ammonia should be included in the work-up. NCG was immediately beneficial for the patient described and should be considered for the emergency treatment of neonatal hyperammonemia. Even a very high ammonia may allow for a normal neurological development in infancy (and possibly beyond).

Entities:  

Keywords:  Case report; Hyperammonemia; N-acetyl glutamate synthase deficiency; Neonatal coma

Year:  2017        PMID: 28275973      PMCID: PMC5740051          DOI: 10.1007/8904_2017_13

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  10 in total

1.  Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators.

Authors:  S Picca; C Dionisi-Vici; D Abeni; A Pastore; C Rizzo; M Orzalesi; G Sabetta; G Rizzoni; A Bartuli
Journal:  Pediatr Nephrol       Date:  2001-11       Impact factor: 3.714

2.  Long-term outcome and intervention of urea cycle disorders in Japan.

Authors:  Jun Kido; Kimitoshi Nakamura; Hiroshi Mitsubuchi; Toshihiro Ohura; Masaki Takayanagi; Masafumi Matsuo; Makoto Yoshino; Yosuke Shigematsu; Tohru Yorifuji; Mureo Kasahara; Reiko Horikawa; Fumio Endo
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

Review 3.  Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.

Authors:  Johannes Häberle
Journal:  Arch Biochem Biophys       Date:  2013-04-27       Impact factor: 4.013

4.  Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

Authors:  M Msall; M L Batshaw; R Suss; S W Brusilow; E D Mellits
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

5.  Early treatment of a child with NAGS deficiency using N-carbamyl glutamate results in a normal neurological outcome.

Authors:  Anouk Van Leynseele; Anna Jansen; Philippe Goyens; Geert Martens; Stefaan Peeters; An Jonckheere; Linda De Meirleir
Journal:  Eur J Pediatr       Date:  2014-12       Impact factor: 3.183

6.  Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency.

Authors:  Peter Gessler; Peter Buchal; Hans U Schwenk; Bendicht Wermuth
Journal:  Eur J Pediatr       Date:  2009-06-17       Impact factor: 3.183

Review 7.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

Review 8.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

9.  Understanding N-Acetyl-L-Glutamate Synthase Deficiency: Mutational Spectrum, Impact of Clinical Mutations on Enzyme Functionality, and Structural Considerations.

Authors:  Enea Sancho-Vaello; Clara Marco-Marín; Nadine Gougeard; Leonor Fernández-Murga; Véronique Rüfenacht; Merima Mustedanagic; Vicente Rubio; Johannes Häberle
Journal:  Hum Mutat       Date:  2016-05-06       Impact factor: 4.878

Review 10.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

  10 in total
  3 in total

Review 1.  Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.

Authors:  Susan E Waisbren; Arianna K Stefanatos; Teresa M Y Kok; Burcu Ozturk-Hismi
Journal:  J Inherit Metab Dis       Date:  2019-08-01       Impact factor: 4.982

2.  Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family.

Authors:  Katell Peoc'h; Léna Damaj; Romain Pelletier; Charles Lefèvre; Christèle Dubourg; Marie-Christine Denis; Claude Bendavid; Sylvie Odent; Caroline Moreau
Journal:  Mol Genet Metab Rep       Date:  2020-01-24

Review 3.  Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.

Authors:  Aileen Kenneson; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2020-10-09       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.